An Open‐Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7‐Day Triple Therapy With Bismuth Versus 14‐Day Standard Triple Therapy for <scp> <i>Helicobacter pylori</i> </scp> Eradication in Children and Adolescents
Adding bismuth to a 7 day triple regimen achieved high eradication rates and a safety profile similar to 14 day standard triple therapy, supporting its use as an effective and safe treatment option for pediatric H. pylori infection.
Authors
- Anja Šterbenc
- Bor Vratanar (ORCID: https://orcid.org/0000-0002-6518-4475)
- Matjaž Homan (ORCID: https://orcid.org/0000-0001-5764-5430)
- Eva Miler Mojškerc
Institutions
- University of Ljubljana (SI)
- Šolski center Slovenj Gradec (SI)
Publication Details
- Journal
- Helicobacter
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1111/hel.70103
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Javna Agencija za Raziskovalno Dejavnost RS